AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 14

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.12 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-021164SemaglutidePPGPPG-2408-B6709Nordanalyt2025-Q198.645.39—Buyer-sourced0PASS
AX-2025-020294BPC-157GGPepsGGPE-2502-S2559Medutest2025-Q198.652.9991.9Buyer-sourced0PASS
AX-2025-020064P21SWBSWB-2408-T8372Janoshik2025-Q199.258.45—Buyer-sourced0PASS
AX-2025-019714L-Glutathione (reduced)HomopeptideHOMO-2408-R3237Janoshik2025-Q198.768.96—Buyer-sourced1MARGINAL
AX-2025-019351BPC-157HYBHYB-2502-R6185Medutest2025-Q199.935.20101.9Buyer-sourced0PASS
AX-2025-018641TirzepatideQSCQSC-2408-T5296Janoshik2025-Q199.935.85—Buyer-sourced1MARGINAL
AX-2025-018436SemaglutideWWBWWB-2501-Y2776Medutest2025-Q199.384.01—Buyer-sourced0PASS
AX-2025-021224BPC-157PPGPPG-2412-N7907Janoshik2025-Q199.934.3895.6Buyer-sourced0PASS
AX-2025-019624SemaglutideTFCTFC-2502-L2101Janoshik2025-Q198.243.7496.4Buyer-sourced0PASS
AX-2025-019350TirzepatideHYBHYB-2408-W6301VendorInvestigate2025-Q197.964.27105.7Buyer-sourced2MARGINAL
AX-2025-019177Enclomiphene citrateSinoPepSNP-2412-F3914Janoshik2025-Q199.205.14—Buyer-sourced2FAIL
AX-2025-018955TirzepatideASYASY-{CAT}-1244PeptideMeter2025-Q198.845.0597.8Buyer-sourced0PASS
AX-2025-018832BPC-157FGPFGP-2409-Y8596PeptideMeter2025-Q199.934.87—Buyer-sourced0PASS
AX-2025-018766BPC-157QSCQSC-2412-D7527Janoshik2025-Q199.236.0099.6Buyer-sourced0PASS
AX-2025-020951BPC-157WXTWXT-2501-J3079Kestrel2025-Q198.885.80—Buyer-sourced0PASS
AX-2025-020926PT-141 (Bremelanotide)WXTWXT-2410-M2421Nordanalyt2025-Q198.275.23—Buyer-sourced0FAIL
AX-2025-020310CJC-1295 (no DAC)GGPepsGGPE-2408-G2525PeptideMeter2025-Q198.453.33—Buyer-sourced0PASS
AX-2025-019664AfamelanotideTFCTFC-2502-Y2346Janoshik2025-Q199.004.98102.8Buyer-sourced1MARGINAL
AX-2025-018834CJC-1295 (no DAC)FGPFGP-2503-P8516PeptideMeter2025-Q199.426.35—Buyer-sourced0PASS
AX-2025-018722Kisspeptin-10QSCQSC-2412-W6783Janoshik2025-Q199.425.72105.6Buyer-sourced0PASS
AX-2025-021130EpitalonSIGSIG-2412-6325PeptideMeter2025-Q198.847.59102.8Buyer-sourced0FAIL
AX-2025-020215SemaglutideGGPepsGGPE-2501-W1875Kestrel2025-Q199.936.00—Supplier-supplied1MARGINAL
AX-2025-019901TirzepatideHJHJ-2501-P5963Janoshik2025-Q199.212.6696.4Supplier-supplied0PASS
AX-2025-019823KPVHomopeptideHOMO-2411-P5026Medutest2025-Q198.755.0899.8Buyer-sourced0FAIL
AX-2025-019685Melanotan IITFCTFC-2410-R2237PeptideMeter2025-Q199.256.0093.5Buyer-sourced0PASS
AX-2025-018924CJC-1295 with DACTFSTFS-{CAT}-9795Janoshik2025-Q199.363.1390.8Buyer-sourced2MARGINAL
AX-2025-018768BPC-157QSCQSC-2412-D7527Janoshik2025-Q199.765.87101.7Buyer-sourced0PASS
AX-2025-018682TB-500QSCQSC-2411-X6249Medutest2025-Q199.935.3191.4Buyer-sourced0PASS
AX-2025-018672TirzepatideQSCQSC-2410-R5814Kestrel2025-Q199.935.07100.7Buyer-sourced0PASS
AX-2025-020409CJC-1295 with DACMKMMKM-2409-W4971Medutest2025-Q199.103.19—Laboratory-retained1MARGINAL
AX-2025-020315CJC-1295 (no DAC)GGPepsGGPE-2408-G2525Janoshik2025-Q198.722.97—Buyer-sourced0PASS
AX-2025-020256Enclomiphene citrateGGPepsGGPE-2410-S2226Nordanalyt2025-Q198.354.1689.7Buyer-sourced1FAIL
AX-2025-020222SemaglutideGGPepsGGPE-2501-W1875Janoshik2025-Q198.465.8093.6Buyer-sourced0PASS
AX-2025-019191CJC-1295 with DACSinoPepSNP-2412-E4702PeptideMeter2025-Q198.872.87107.3Buyer-sourced0PASS
AX-2025-019144TesamorelinGSPGSP-2501-G3708Kestrel2025-Q198.344.24—Buyer-sourced0PASS
AX-2025-018995HexarelinASYASY-{CAT}-1786Janoshik2025-Q199.804.22—Buyer-sourced0PASS
AX-2025-018741CJC-1295 (no DAC)QSCQSC-2411-D7855Nordanalyt2025-Q199.143.64106.5Buyer-sourced0PASS
AX-2025-018663TirzepatideQSCQSC-2410-R5814Janoshik2025-Q199.515.08—Buyer-sourced0PASS
AX-2025-021170SemaglutidePPGPPG-2408-B6709VendorInvestigate2025-Q198.645.35—Buyer-sourced0PASS
AX-2025-019943AOD-9604HJHJ-2502-E7144Nordanalyt2025-Q198.592.41—Buyer-sourced0PASS